Overview
Emerald has secured $1.2 million in pre-seed funding, bringing its total to $2 million, led by Boost Capital Partners and including notable investors like Mark Fountain and several angel investors. The company addresses fragmented health information by providing baseline tests, a user-friendly dashboard, AI alerts, and personalized GP oversight. With over 10,000 users and a 15% monthly growth rate, Emerald shows strong market traction and aims to shift healthcare from reactive to proactive.
Products
Loading...
Recent Deals
Investors: Boost Capital Partners, Mark Fountain
Emerald has secured $1.2 million in pre-seed funding, bringing its total to $2 million, led by Boost Capital Partners and including notable investors like Mark Fountain and several angel investors. The company addresses fragmented health information by providing baseline tests, a user-friendly dashboard, AI alerts, and personalized GP oversight. With over 10,000 users and a 15% monthly growth rate, Emerald shows strong market traction and aims to shift healthcare from reactive to proactive.